Ashtead to be quizzed over growth outlook after lacklustre performance

Who’s tipping what The week’s best shares ...

Companies in the news and how they were assessed

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Reaction suggests investors may no longer swayed by earnings ‘beats’

VEHICLES WHOSE DIVIDEND PAYOUTS HAVE BEATEN RISING PRICES